1063 related articles for article (PubMed ID: 12609773)
21. Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C.
Legerski R; Peterson C
Nature; 1992 Sep; 359(6390):70-3. PubMed ID: 1522891
[TBL] [Abstract][Full Text] [Related]
22. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
[TBL] [Abstract][Full Text] [Related]
23. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
24. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
25. [Xeroderma pigmentosum].
Ueda M; Ichihashi M
Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
[TBL] [Abstract][Full Text] [Related]
26. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients.
Otto AI; Riou L; Marionnet C; Mori T; Sarasin A; Magnaldo T
Cancer Res; 1999 Mar; 59(6):1212-8. PubMed ID: 10096550
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients.
Couvé-Privat S; Le Bret M; Traiffort E; Queille S; Coulombe J; Bouadjar B; Avril MF; Ruat M; Sarasin A; Daya-Grosjean L
Cancer Res; 2004 May; 64(10):3559-65. PubMed ID: 15150112
[TBL] [Abstract][Full Text] [Related]
28. The genetic basis of xeroderma pigmentosum.
Bootsma D; Hoeijmakers JH
Ann Genet; 1991; 34(3-4):143-50. PubMed ID: 1809220
[TBL] [Abstract][Full Text] [Related]
29. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L; Sarasin A
Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
[TBL] [Abstract][Full Text] [Related]
30. Abnormal sensitivity of human fibroblasts from xeroderma pigmentosum variants to transformation to anchorage independence by ultraviolet radiation.
McCormick JJ; Kateley-Kohler S; Watanabe M; Maher VM
Cancer Res; 1986 Feb; 46(2):489-92. PubMed ID: 3940626
[TBL] [Abstract][Full Text] [Related]
31. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
[TBL] [Abstract][Full Text] [Related]
32. Characterization of molecular defects in xeroderma pigmentosum group C.
Li L; Bales ES; Peterson CA; Legerski RJ
Nat Genet; 1993 Dec; 5(4):413-7. PubMed ID: 8298653
[TBL] [Abstract][Full Text] [Related]
33. [Multiple facial squamous cell carcinomas in a child, revealing a xeroderma pigmentosum].
Beogo R; Andonaba JB; Bouletreau P; Traore Sawadogo H; Traore A
Rev Stomatol Chir Maxillofac; 2012 Feb; 113(1):50-2. PubMed ID: 22056175
[TBL] [Abstract][Full Text] [Related]
34. Complementation assays adapted for DNA repair-deficient keratinocytes.
Fréchet M; Bergoglio V; Chevallier-Lagente O; Sarasin A; Magnaldo T
Methods Mol Biol; 2006; 314():9-23. PubMed ID: 16673870
[TBL] [Abstract][Full Text] [Related]
35. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
36. Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5.
O'Donovan A; Wood RD
Nature; 1993 May; 363(6425):185-8. PubMed ID: 8483505
[TBL] [Abstract][Full Text] [Related]
37. [A whole family affected by xeroderma pigmentosum: clinical and genetic particularities].
Zghal M; Fazaa B; Zghal A; Mokhtar I; Sarasin A; Kamoun MR; Gharbi MR
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):31-6. PubMed ID: 12605154
[TBL] [Abstract][Full Text] [Related]
38. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.
Kondo S; Mamada A; Miyamoto C; Keong CH; Satoh Y; Fujiwara Y
Photodermatol; 1989 Apr; 6(2):89-95. PubMed ID: 2664729
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
40. Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches.
Lehmann J; Schubert S; Emmert S
J Dtsch Dermatol Ges; 2014 Oct; 12(10):867-72. PubMed ID: 25262888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
